Legal Representation
Attorney
Mark D. Hansing
USPTO Deadlines
Application History
8 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 5, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Jun 5, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Feb 12, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Feb 12, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Feb 12, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 5, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sep 23, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Development of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedical products, and pharmaceuticals; medical laboratory services and scientific laboratory services; biomedical research services; biotechnology research; chemical research; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; drug discovery services; industrial research in the field of regenerative and reparative therapies; medical research; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; scientific research and development; technology research in the field of regenerative and reparative therapies; pharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, and regenerative medicine; scientific research for medical purposes in the area of regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; providing medical and scientific research information relating to medical treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration; clinical research in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and pharmaceutical preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of pharmaceutical preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and tissue generation, processing and transplantation; scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials
Classification
International Classes
042